Stock listing

BCRX Stock Price, News, Filings & Events — Biocryst Pharmaceuticals, Inc.

Selected listing: BCRX · BOATS · USD · US

This page tracks Biocryst Pharmaceuticals, Inc.'s BCRX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BCRX:BOATS. BCRX:BOATS is the stock-level entry point for investors researching Biocryst Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biocryst Pharmaceuticals, Inc. (BCRX) is a public company based in the United States, specializing in the development of innovative therapies for rare diseases. The company has a market capitalization of approximately $2.37 billion. Biocryst focuses on creating treatments that address unmet medical needs, leveraging its expertise in biopharmaceuticals.

BCRX:BOATSUSDUSUpdated August 21, 2026
Biocryst Pharmaceuticals, Inc. logo
Ticker
BCRX:BOATS
Asset type
Stock
Market cap
$2.44B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Biocryst Pharmaceuticals, Inc. BCRX:BOATS stock context

This page tracks Biocryst Pharmaceuticals, Inc.'s BCRX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BCRX:BOATS. BCRX:BOATS is the stock-level entry point for investors researching Biocryst Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biocryst Pharmaceuticals, Inc. (BCRX) is a public company based in the United States, specializing in the development of innovative therapies for rare diseases. The company has a market capitalization of approximately $2.37 billion. Biocryst focuses on creating treatments that address unmet medical needs, leveraging its expertise in biopharmaceuticals.

Latest news from Biocryst Pharmaceuticals, Inc.

All Biocryst Pharmaceuticals, Inc. news →

Research Biocryst Pharmaceuticals, Inc.

Alternate listings